Stuart Poulton Karyopharm Therapeutics Inc. (KPTI) insider trading activity

KPTI Quotes by TradingView

Stuart Poulton is EVP, Chief Development Officer of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 326,628 shares of KPTI, which is worth approximately $209,041. The most recent transaction as insider was on Jul 30, 2024, when has been sold 2,883 shares (Common Stock) at a price of $1.06 per share, resulting in proceeds of $3,055. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 327K
0% 3M change
108.99% 12M change
Total Value Held $209,041

Stuart Poulton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 30 2024
SELL
Open market or private sale
$3,055 $1.06 p/Share
2,883 Reduced 0.87%
326,628 Common Stock
Mar 01 2024
SELL
Open market or private sale
$7,386 $1.2 p/Share
6,155 Reduced 1.83%
329,511 Common
Feb 29 2024
SELL
Open market or private sale
$19,083 $1.17 p/Share
16,311 Reduced 4.63%
335,666 Common
Feb 28 2024
BUY
Grant, award, or other acquisition
-
188,205 Added 34.84%
351,977 Common Stock
Feb 15 2024
SELL
Open market or private sale
$8,010 $1.37 p/Share
5,847 Reduced 3.45%
163,772 Common Stock
Jan 24 2024
BUY
Grant, award, or other acquisition
-
13,333 Added 7.29%
169,619 Common Stock
Jul 28 2023
SELL
Open market or private sale
$4,836 $1.7 p/Share
2,845 Reduced 1.79%
156,286 Common Stock
Feb 28 2023
BUY
Grant, award, or other acquisition
-
95,000 Added 37.38%
159,131 Common Stock
Feb 15 2023
SELL
Open market or private sale
$18,722 $3.19 p/Share
5,869 Reduced 8.38%
64,131 Common Stock
SP

Stuart Poulton

EVP, Chief Development Officer
Newton, MA

Track Institutional and Insider Activities on KPTI

Follow Karyopharm Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPTI shares.

Notify only if

Insider Trading

Get notified when an Karyopharm Therapeutics Inc. insider buys or sells KPTI shares.

Notify only if

News

Receive news related to Karyopharm Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KPTI